AstraZeneca gets its third regulatory green light in a matter of weeks for asthma drugProactive Investors • 09/27/22
Ionis Pharmaceuticals Nosedives After AstraZeneca Drops High Cholesterol Drug TestInvestors Business Daily • 09/23/22
AstraZeneca wins European approval for Ultomiris autoimmune disease treatmentProactive Investors • 09/23/22
LogicBio® Therapeutics Announces Pre-Clinical Results for mLB-001 Published in Peer-reviewed Journal PLOS ONEPRNewsWire • 09/21/22
AstraZeneca Partners with Jeff Bridges, Kumail Nanjiani, and Emily V. Gordon to Educate the Immunocompromised Community about Added Protection Against COVID-19Business Wire • 09/15/22
AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts sayMarket Watch • 09/14/22
ENHERTU® Continues to Demonstrate Clinically Meaningful Tumor Response in Patients with HER2 Mutant Metastatic Non-Small Cell Lung CancerBusiness Wire • 09/11/22
Gatehouse Bio Extends Its Partnership with AstraZeneca to Develop RNA Therapeutics for Heart FailureBusiness Wire • 09/08/22